Abstract
The dimethyl derivative of the immunomodulator itaconate has been previously shown to have anti-inflammatory, anti-oxidative, and immunomodulatory effects. In the present work, we evaluate the potential of dimethyl itaconate as an anti-angiogenic compound by using cultured endothelial cells and several in vitro assays that simulate key steps of the angiogenic process, including endothelial cell proliferation, migration, invasion, and tube formation. Our results show that dimethyl itaconate interferes with all the previously mentioned steps of the angiogenic process, suggesting that dimethyl itaconate behaves as an anti-angiogenic compound.
Funder
MICINN and FEDER
Andalusian Government and FEDER
Andalusian Government
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference37 articles.
1. The immunomodulatory potential of the metabolite itaconate;Hooftman;Trends Immunol.,2019
2. Krebs cycle reborn in macrophage immunometabolism;Ryan;Annu. Rev. Immunol.,2020
3. Itaconate: A metabolite regulates inflammation response and oxidative stress;Li;Oxid. Med. Cell. Longev.,2020
4. The role of itaconate in host defense and inflammation;Peace;J. Clin. Investig.,2022
5. The itaconate family of immunomodulators grow;McGettrick;Nat. Metab.,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献